FI892248L - Menetelmä ranitidiinin hartsiadsorbaatin valmistamiseksi - Google Patents

Menetelmä ranitidiinin hartsiadsorbaatin valmistamiseksi Download PDF

Info

Publication number
FI892248L
FI892248L FI892248A FI892248A FI892248L FI 892248 L FI892248 L FI 892248L FI 892248 A FI892248 A FI 892248A FI 892248 A FI892248 A FI 892248A FI 892248 L FI892248 L FI 892248L
Authority
FI
Finland
Prior art keywords
resin adsorbate
preparing ranitidine
preparing
ranitidine resin
adsorbate
Prior art date
Application number
FI892248A
Other languages
English (en)
Swedish (sv)
Other versions
FI92060B (fi
FI892248A0 (fi
FI92060C (fi
Inventor
Stephen John Douglas
Fiona Ruth Bird
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888811167A external-priority patent/GB8811167D0/en
Priority claimed from GB888816185A external-priority patent/GB8816185D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI892248A0 publication Critical patent/FI892248A0/fi
Publication of FI892248L publication Critical patent/FI892248L/fi
Publication of FI92060B publication Critical patent/FI92060B/fi
Application granted granted Critical
Publication of FI92060C publication Critical patent/FI92060C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
FI892248A 1988-05-11 1989-05-10 Menetelmä ranitidiinin hartsiadsorbaatin valmistamiseksi FI92060C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888811167A GB8811167D0 (en) 1988-05-11 1988-05-11 Medicaments
GB8811167 1988-05-11
GB888816185A GB8816185D0 (en) 1988-07-07 1988-07-07 Medicaments
GB8816185 1988-07-07

Publications (4)

Publication Number Publication Date
FI892248A0 FI892248A0 (fi) 1989-05-10
FI892248L true FI892248L (fi) 1989-11-12
FI92060B FI92060B (fi) 1994-06-15
FI92060C FI92060C (fi) 1994-09-26

Family

ID=26293879

Family Applications (1)

Application Number Title Priority Date Filing Date
FI892248A FI92060C (fi) 1988-05-11 1989-05-10 Menetelmä ranitidiinin hartsiadsorbaatin valmistamiseksi

Country Status (35)

Country Link
US (1) US5032393A (fi)
JP (1) JP2944678B2 (fi)
KR (1) KR890016968A (fi)
CN (1) CN1027133C (fi)
AT (1) AT401614B (fi)
AU (1) AU624613B2 (fi)
BE (1) BE1002159A5 (fi)
CA (1) CA1337272C (fi)
CH (1) CH679011A5 (fi)
CY (1) CY1781A (fi)
DE (1) DE3915347C2 (fi)
DK (1) DK168934B1 (fi)
ES (1) ES2011573A6 (fi)
FI (1) FI92060C (fi)
FR (1) FR2631232B1 (fi)
GB (1) GB2218333B (fi)
GR (1) GR1000358B (fi)
HK (1) HK45094A (fi)
HU (2) HU204994B (fi)
IE (1) IE60722B1 (fi)
IL (1) IL90245A (fi)
IT (1) IT1232831B (fi)
LU (1) LU87515A1 (fi)
MX (1) MX173349B (fi)
MY (1) MY104013A (fi)
NL (1) NL8901188A (fi)
NO (1) NO175131C (fi)
NZ (1) NZ229064A (fi)
PH (1) PH27612A (fi)
PL (1) PL279377A1 (fi)
PT (1) PT90523B (fi)
RU (1) RU2033155C1 (fi)
SE (1) SE508343C2 (fi)
SG (1) SG48194G (fi)
YU (1) YU47674B (fi)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219563A (en) * 1988-05-11 1993-06-15 Glaxo Group Limited Drug adsorbates
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8904182D0 (en) * 1989-02-23 1989-04-05 Glaxo Canada Pharmaceutical compositions
SE9003902D0 (sv) * 1990-12-07 1990-12-07 Astra Ab Solid dosage forms of a drug
GB8925484D0 (en) * 1989-11-10 1989-12-28 Glaxo Group Ltd Process
AU8546591A (en) * 1990-09-13 1992-04-15 Smithkline Beecham Corporation Non-aqueous liquid oral suspensions
SE9003903D0 (sv) * 1990-12-07 1990-12-07 Astra Ab New pharmaceutical formulations
HUT74642A (en) * 1990-12-21 1997-01-28 Richardson Vicks Inc Polyamine drug-resin complex
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
JP3207494B2 (ja) * 1992-04-02 2001-09-10 ロート製薬株式会社 水性懸濁製剤
JP3278192B2 (ja) * 1992-04-03 2002-04-30 ロート製薬株式会社 徐放性液剤
GB9211148D0 (en) * 1992-05-26 1992-07-08 Smithkline Beecham Plc Novel treatment
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
MX9306393A (es) * 1992-10-16 1994-04-29 Glaxo Group Ltd Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen.
EP0687174B1 (en) * 1993-03-05 2001-06-13 Hexal Ag Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation
NO941358L (no) * 1993-04-16 1994-10-17 Mcneil Ppc Inc Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav
GB9324409D0 (en) * 1993-11-27 1994-01-12 Smithkline Beecham Plc Novel composition
DK171127B1 (da) * 1994-04-22 1996-06-24 Gea Farmaceutisk Fabrik As Ranitidintablet med et hydroxypropylmethylcelluloseholdigt overtræk samt fremgangsmåde til at tilvejebringe dette overtræk
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
RU2131264C1 (ru) * 1996-06-04 1999-06-10 Московское производственное химико-фармацевтическое объединение им.Н.А.Семашко Противоязвенное средство в виде таблеток и способ его получения
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
CA2305179A1 (en) * 1997-09-30 1999-04-08 Daiichi Pharmaceutical Co., Ltd. Oral administration preparation
JP4283355B2 (ja) * 1997-11-10 2009-06-24 久光製薬株式会社 薬剤用徐放化剤及びそれを含有した徐放性医薬組成物
CA2309597A1 (en) * 1997-11-10 1999-05-20 Hiroshi Sorimachi Sustainedly releasing agents for medicines and sustainedly released medicinal compositions containing the same
RU2154469C2 (ru) * 1998-08-10 2000-08-20 Открытое акционерное общество фармацевтическая фирма "ЗДОРОВЬЕ" Способ получения таблеток ранитидина
RU2385155C2 (ru) * 1998-08-18 2010-03-27 Федеральное Государственное Унитарное Предприятие Государственный Научно-Исследовательский Институт "Биоэффект" (Фгуп Гнии "Биоэффект") Физически устойчивая рентгеноаморфная форма ранитидина гидрохлорида с повышенной противоязвенной активностью и способ ее получения
US6514492B1 (en) 1999-07-14 2003-02-04 Schering-Plough Veterinary Corporation Taste masking of oral quinolone liquid preparations using ion exchange resins
PT1200129E (pt) * 1999-07-14 2008-12-17 Schering Plough Ltd Máscara de sabor para preparações orais líquidas de quinolona com utilização de resinas de permuta iónica
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
US7067116B1 (en) * 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
US20020031490A1 (en) * 2000-07-27 2002-03-14 Bellamy Simon Andrew Method for preparing resinates
US20030099711A1 (en) * 2001-08-29 2003-05-29 David Meadows Sustained release preparations
CN1615156B (zh) * 2002-01-18 2012-05-30 罗门哈斯公司 制备树脂酸酯的方法
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
US20050142097A1 (en) * 2003-12-29 2005-06-30 Deepak Thassu Multiple active drug resin conjugate
US20050265955A1 (en) * 2004-05-28 2005-12-01 Mallinckrodt Inc. Sustained release preparations
EP1898913A1 (en) * 2005-06-28 2008-03-19 Ucb, S.A. Multiple active drug-resin conjugate
AU2006292946B2 (en) * 2005-09-21 2009-12-10 Chong Kun Dang Pharmaceutical Corp. Novel resinate complex of s-clopidogrel and production method thereof
ATE536867T1 (de) 2006-03-16 2011-12-15 Tris Pharma Inc Modifizierte freisetzungsformulierungen mit arznei-ion-austausch-harzkomplexen
CN100411626C (zh) * 2006-08-28 2008-08-20 浙江大学 缓释型碘补充剂的制备方法
US8287848B2 (en) 2006-10-03 2012-10-16 Tris Pharma Inc Formulations containing an ionic mineral-ion exchange resin complex and uses thereof
CN100450548C (zh) * 2006-12-22 2009-01-14 江苏奥赛康药业有限公司 一种波拉克林树脂组合物的口腔贴片及其制备方法
EA021392B1 (ru) * 2007-10-11 2015-06-30 Филип Моррис Продактс С.А. Бездымный табачный продукт
WO2009102830A1 (en) * 2008-02-13 2009-08-20 Eurand Inc Orally disintegrating tablet compositions of ranitidine and methods of manufacture
JP5560701B2 (ja) * 2008-12-26 2014-07-30 ライオン株式会社 ラニチジン含有医薬固形製剤及びラニチジン担持粒子の製造方法
JP5412966B2 (ja) * 2009-06-08 2014-02-12 ライオン株式会社 粒状製剤
US8357398B2 (en) * 2009-10-21 2013-01-22 Alitair Pharmaceuticals Inc. Benzonatate compositions and methods of use
CN102198118B (zh) * 2011-03-28 2012-08-29 于晓勇 一种治疗呕吐的口腔药物制剂及其制备方法
CN102138915A (zh) * 2011-03-28 2011-08-03 于晓勇 一种口服药物制剂及其制备方法
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
CN109890368B (zh) * 2016-11-01 2021-12-21 强生消费者公司 包含组胺h2受体拮抗剂和抗酸剂的液体口服药物剂型
CN112020350A (zh) 2018-04-27 2020-12-01 强生消费者公司 液体口服药物剂型

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR803638A (fr) * 1935-06-21 1936-10-05 Système de freinage pour portes coulissantes
US2828207A (en) * 1955-11-14 1958-03-25 Du Pont Fortification of feed
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US2970053A (en) * 1958-10-28 1961-01-31 Pfizer & Co C Oleandomycin resin adsorbate
US3138525A (en) * 1961-06-16 1964-06-23 Hoffmann La Roche Castor wax-amprotropine-resin compositions
US3949068A (en) * 1964-02-20 1976-04-06 University Of Alabama In Birmingham Medical And Educational Foundation Pharmaceutical compositions
GB1180233A (en) * 1966-02-23 1970-02-04 Jean Astruc Modified Spiramycin
US3624209A (en) * 1966-12-28 1971-11-30 Bristol Myers Co Composition for treatment of gastro-intestinal disorders
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
JPS5146154B2 (fi) * 1972-05-11 1976-12-07
GB1462356A (en) * 1973-07-10 1977-01-26 Beecham Group Ltd Pharmaceutical compositions
JPS51125708A (en) * 1974-07-23 1976-11-02 Beecham Group Ltd Production of betaalactam antibiotic complex
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
CY1306A (en) * 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
NZ215069A (en) * 1985-03-01 1988-06-30 Reckitt & Colmann Prod Ltd Pharmaceutical composition with histamine h 2 -receptor antagonist
US4788055A (en) * 1985-12-09 1988-11-29 Ciba-Geigy Corporation Resinate sustained release dextromethorphan composition
JPS6369038A (ja) * 1986-09-10 1988-03-29 Canon Inc 光カ−ド記録媒体
US4795641A (en) * 1987-08-20 1989-01-03 Eastman Kodak Company Polymer blends having reverse phase morphology for controlled delivery of bioactive agents

Also Published As

Publication number Publication date
MX173349B (es) 1994-01-22
SG48194G (en) 1994-11-25
PH27612A (en) 1993-08-31
JP2944678B2 (ja) 1999-09-06
IL90245A0 (en) 1989-12-15
MX15983A (es) 1993-10-01
FI92060B (fi) 1994-06-15
NO175131B (no) 1994-05-30
NO891906D0 (no) 1989-05-10
JPH02111719A (ja) 1990-04-24
ES2011573A6 (es) 1990-01-16
CN1037651A (zh) 1989-12-06
DK229489D0 (da) 1989-05-10
GB8910706D0 (en) 1989-06-28
ATA112089A (de) 1996-03-15
GB2218333A (en) 1989-11-15
AU3461789A (en) 1989-11-16
CY1781A (en) 1995-10-20
DK168934B1 (da) 1994-07-11
DE3915347C2 (de) 1994-11-03
GB2218333B (en) 1991-11-06
SE8901671L (sv) 1989-11-12
HUT50036A (en) 1989-12-28
IT8947938A0 (it) 1989-05-10
DK229489A (da) 1989-11-12
NZ229064A (en) 1991-12-23
IE60722B1 (en) 1994-08-10
MY104013A (en) 1993-10-30
RU2033155C1 (ru) 1995-04-20
IT1232831B (it) 1992-03-05
YU47674B (sh) 1996-01-08
NO891906L (no) 1989-11-13
SE508343C2 (sv) 1998-09-28
CN1027133C (zh) 1994-12-28
HU211592A9 (en) 1995-12-28
YU97189A (en) 1990-06-30
DE3915347A1 (de) 1989-11-16
HU204994B (en) 1992-03-30
CH679011A5 (fi) 1991-12-13
FR2631232B1 (fr) 1993-11-19
GR1000358B (el) 1992-06-30
KR890016968A (ko) 1989-12-14
FI892248A0 (fi) 1989-05-10
AT401614B (de) 1996-10-25
BE1002159A5 (fr) 1990-08-14
IL90245A (en) 1994-04-12
CA1337272C (en) 1995-10-10
IE891527L (en) 1989-11-11
FR2631232A1 (fr) 1989-11-17
SE8901671D0 (sv) 1989-05-10
HK45094A (en) 1994-05-13
NO175131C (no) 1994-09-07
US5032393A (en) 1991-07-16
GR890100314A (en) 1990-03-12
LU87515A1 (fr) 1990-06-12
PT90523A (pt) 1989-11-30
NL8901188A (nl) 1989-12-01
PL279377A1 (en) 1990-01-22
PT90523B (pt) 1994-10-31
AU624613B2 (en) 1992-06-18
FI92060C (fi) 1994-09-26

Similar Documents

Publication Publication Date Title
FI892248L (fi) Menetelmä ranitidiinin hartsiadsorbaatin valmistamiseksi
FI893158L (fi) Menetelmä tetrahydrofolaattien valmistamiseksi
FI894217L (fi) 1-adamantaanijohdannaisten valmistusmenetelmä
FI892649L (fi) Menetelmä kudosliiman valmistamiseksi
FI884873A7 (fi) Menetelmä absorbenttipolymeerin valmistamiseksi
FI892850L (fi) Menetelmä uusien hepariinijohdannaisten valmistamiseksi
FI904765A7 (fi) Menetelmä tarttuvien polymeerien valmistamiseksi
FI891711L (fi) Menetelmä diorganodialkoksisilaanien valmistamiseksi
FI881743L (fi) Menetelmä bifunktionaalisten proteiinien valmistamiseksi
FI891074L (fi) Menetelmä syklisten sulfaattien valmistamiseksi
FI895766A7 (fi) Menetelmä uusien lysosfingolipidien valmistamiseksi
FI891700L (fi) Menetelmä beta-laktaamijohdannaisten valmistamiseksi
FI893519A7 (fi) Menetelmä Lys-plasminogeenin valmistamiseksi
FI884179L (fi) Menetelmä hemoglobiinin mittaamiseksi
FI892129A7 (fi) Parannettu menetelmä ketimiinin valmistamiseksi
FI891129A7 (fi) Menetelmä buteeni-I:n valmistamiseksi
FI891677L (fi) Menetelmä 4-demetoksidaunomysinonin valmistamiseksi
FI903906A7 (fi) Menetelmä neoalkyylitriolitriestereiden valmistamiseksi
FI891362A7 (fi) Menetelmä uusien alkanofenonien valmistamiseksi
FI895800A7 (fi) Menetelmä uusien a-syano-b-oksopropioniamidien valmistamiseksi
FI893901L (fi) Menetelmä tetrasyklisten masennuslääkkeiden valmistamiseksi
NO171910C (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler
IT1237508B (it) Procedimento per preparare n-fosfonometilglicina.
FI885652L (fi) Menetelmä olefiinipolymeerin valmistamiseksi
FI892327A7 (fi) Menetelmä syklisten sulfaattien valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: GLAXO GROUP LIMITED